The first European fund of funds investing 100% in underlyings (both shares of funds investing in equity and in bonds) with high ESG ratings through a strategy that invests 50% of the portfolio into SRI equity funds and 50% into SRI bond funds.
The main objective of this Sub-Fund is to generate a capital growth and to provide income over the medium term by investing mainly equity, fixed income and money market instruments.
J. LAMARCK BIOTECH
The main objective of this fund is to profit from increasing share prices in the biotechnology sector.
J. LAMARCK PHARMA
The main objective of this fund is to profit from increasing share prices in the pharmaceutical sector.
Questo sito utilizza cookie tecnici e cookie di terze parti per assicurare una migliore esperienza ai nostri utenti. Navigando sul nostro sito, l'utente accetta le nostre modalità d'uso dei cookie. Info - OkReject
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.